Nuvo Overview
Nuvo is committed to reinventing pregnancy care through new technology, tools, and practices for providers and expectant mothers, including the INVU by Nuvo platform, an FDA-cleared, prescription initiated remote pregnancy monitoring and management system. INVU enables providers to conduct virtual well-being checks and remote non-stress-tests with expectant moms from anywhere, keeping patients and doctors connected at a time when it is needed most.
Cumulative Funding Raised Over Time ($)
$48.0MJun 2018
$58.0MMay 2021
$58.0MMay 2025
Latest News
growth-negative
ATTENTION DIRECT AND INDIRECT HOLDERS OF SECURITIES ISSUED BY HOLDCO NUVO GROUP D.G LTD.: The United States Bankruptcy Court for the District of Delaware has entered an order that imposes substantial restrictions on trading in equity interests in Holdco Nuvo Group D.G Ltd. and affiliates
Holdco Nuvo Group D.G Ltd. has announced that the United States Bankruptcy Court for the District of Delaware has imposed significant restrictions on trading in the companys equity interests. This development is part of a bankruptcy case, with the case number 24-11880 (MFW). The order and further details can be accessed online, and inquiries can be directed to Epiq Corporate Restructuring, LLC or the proposed counsel for the debtors. This court order is expected to have a negative impact on the companys growth prospects.
Public Trading
growth-positive
Nuvo Group Adds HealthTech Veteran Adriana Machado to Board of Directors, Strengthening Company’s Commitment to Transforming Prenatal Care
Holdco Nuvo Group D.G Ltd, a pioneer in remote pregnancy monitoring, announced the expansion of its board of directors with the addition of Adriana Machado. Machado brings extensive experience in business leadership, strategic planning, and international relations, and will help guide Nuvo’s mission of addressing health disparities and social determinants of care. Nuvo, which recently listed on NASDAQ, aims to expand its footprint in the US and Israel and plans to introduce its INVU platform in Europe in 2024. The company is focused on providing remote pregnancy monitoring and improving access to care for expectant mothers globally.
Management Changes
growth-positive
Remote Pregnancy Monitoring Company Nuvo Goes Public Through Merger with LAMF Global Ventures -
Nuvo Group, a company specializing in remote pregnancy monitoring, has completed its business combination with LAMF Global Ventures, transitioning into a publicly traded company on NASDAQ under the ticker symbol NUVO. The companys INVU platform, an FDA-cleared pregnancy monitoring and management system, uses wearable technology, AI, and machine learning to provide real-time insights into maternal and fetal health. The business combination will allow Nuvo to access capital markets to fuel commercial growth, international expansion, and expedite its innovation pipeline.
Public TradingExpand
growth-positive
Nuvo Group Completes Merger with LAMF Global Ventures I | DealFlow's SPAC News
Nuvo Group, an Israel-based company that provides a pregnancy monitoring and management platform, has completed its business combination with LAMF Global Ventures I. As a result, Nuvo shares are now listed on the Nasdaq under the ticker symbol NUVO. The transaction was approved by LAMF’s shareholders on April 1, leaving $434,982 in cash in the trust account. The deal, announced last August, valued Nuvo at a pre-money equity valuation of $269 million, potentially rising to $300 million if Nuvo achieves certain commercial milestones.
Public TradingPartners
growth-positive
LAMF Global Ventures Corp. I Shareholders Approve Previously Announced Business Combination with Nuvo Group Ltd.
Nuvo Group Ltd., a remote pregnancy monitoring platform, and LAMF Global Ventures Corp. I, a publicly traded special purpose acquisition company, have announced that LAMFs shareholders have voted to approve the previously announced business combination between the two companies. The combined company will operate as Holdco and is expected to be listed on Nasdaq under the ticker symbol NUVO. The transaction is expected to close as soon as practicable.
Acquired-byPublic Trading
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $58M |
| Last funding | Undisclosed |
| Stage | Public |
| Rounds | 4 |
| Investors | 5 |
Team Members
5
Employees: 11-50
Web & Social Links
| Website | www.nuvocares.com/home |
| App Store | App Store |
| Google Play | Google Play |
Locations
Yigal Alon Street 94, Tel Aviv-Yafo, Israel
252 Nassau Street, Princeton, NJ, USA
Moskovska Street, 32/2, Kyiv, Ukraine
Photos & Videos
2 item(s)
Nuvo Business
Business models
B2B2C
Product stage
Released
Employees
11-50
Sector
Health Tech & Life SciencesDigital HealthcarePatient Remote MonitoringTarget Customer
Healthcare & Life SciencesHealthcarePatientsInsurance CompaniesProvidersConsumersDemographics & FamilyWomenBabiesCore Technology
Platforms & InterfacesMobileArtificial IntelligenceMachine LearningSemiconductors & ElectronicsWearablesSensingData StorageCloudTags (26)
femtechsensorsremote-monitoringpreventionnon-invasivebabiesbig-datadigital-healthcareconsumer-electronicspregnancygynecologytelehealthwearableartificial-intelligencemachine-learningmobile-applicationscloud-baseddata-analyticsmedical-datacardiologyinsurance-companieshealthcare-providersmhealthpersonalizationdecision-supportwomen-healthGeographic Markets
United KingdomUnited StatesDenmarkNorth AmericaGermanyIsraelEuropeAsiaNuvo Financials
$58M
Total funding
Undisclosed
Capital raised
Undisclosed
Last funding
Public
Funding stage
4
Total rounds
5
Investors
Cumulative Funding Raised Over Time ($)
$48.0MJun 2018
$58.0MMay 2021
$58.0MMay 2025
Private Equity Funding
PIPE
May 2025
Undisclosed
VentureIsrael (Lead)
Undisclosed Round
May 2021
$10M
Kli Capital
Undisclosed Round
Jun 2018
$48M
GEM Capital, Gal Ventures, Value Management AG
Public Offering / Exit
SpacEvent
May 2024
Undisclosed
Nuvo Lifecycle
Cumulative Funding Raised Over Time
$48.0MJun 2018
$58.0MMay 2021
$58.0MMay 2025
All Events
PIPE
May 2025
Undisclosed
VentureIsrael (Lead)
Undisclosed Round
May 2021
$10M
Kli Capital
Undisclosed Round
Jun 2018
$48M
GEM Capital, Gal Ventures, Value Management AG
SpacEvent
May 2024
Undisclosed
Nuvo News
36 articles
growth-negative
ATTENTION DIRECT AND INDIRECT HOLDERS OF SECURITIES ISSUED BY HOLDCO NUVO GROUP D.G LTD.: The United States Bankruptcy Court for the District of Delaware has entered an order that imposes substantial restrictions on trading in equity interests in Holdco Nuvo Group D.G Ltd. and affiliates
Holdco Nuvo Group D.G Ltd. has announced that the United States Bankruptcy Court for the District of Delaware has imposed significant restrictions on trading in the companys equity interests. This development is part of a bankruptcy case, with the case number 24-11880 (MFW). The order and further details can be accessed online, and inquiries can be directed to Epiq Corporate Restructuring, LLC or the proposed counsel for the debtors. This court order is expected to have a negative impact on the companys growth prospects.
Public Trading
growth-positive
Nuvo Group Adds HealthTech Veteran Adriana Machado to Board of Directors, Strengthening Company’s Commitment to Transforming Prenatal Care
Holdco Nuvo Group D.G Ltd, a pioneer in remote pregnancy monitoring, announced the expansion of its board of directors with the addition of Adriana Machado. Machado brings extensive experience in business leadership, strategic planning, and international relations, and will help guide Nuvo’s mission of addressing health disparities and social determinants of care. Nuvo, which recently listed on NASDAQ, aims to expand its footprint in the US and Israel and plans to introduce its INVU platform in Europe in 2024. The company is focused on providing remote pregnancy monitoring and improving access to care for expectant mothers globally.
Management Changes
growth-positive
Remote Pregnancy Monitoring Company Nuvo Goes Public Through Merger with LAMF Global Ventures -
Nuvo Group, a company specializing in remote pregnancy monitoring, has completed its business combination with LAMF Global Ventures, transitioning into a publicly traded company on NASDAQ under the ticker symbol NUVO. The companys INVU platform, an FDA-cleared pregnancy monitoring and management system, uses wearable technology, AI, and machine learning to provide real-time insights into maternal and fetal health. The business combination will allow Nuvo to access capital markets to fuel commercial growth, international expansion, and expedite its innovation pipeline.
Public TradingExpand
growth-positive
Nuvo Group Completes Merger with LAMF Global Ventures I | DealFlow's SPAC News
Nuvo Group, an Israel-based company that provides a pregnancy monitoring and management platform, has completed its business combination with LAMF Global Ventures I. As a result, Nuvo shares are now listed on the Nasdaq under the ticker symbol NUVO. The transaction was approved by LAMF’s shareholders on April 1, leaving $434,982 in cash in the trust account. The deal, announced last August, valued Nuvo at a pre-money equity valuation of $269 million, potentially rising to $300 million if Nuvo achieves certain commercial milestones.
Public TradingPartners
growth-positive
LAMF Global Ventures Corp. I Shareholders Approve Previously Announced Business Combination with Nuvo Group Ltd.
Nuvo Group Ltd., a remote pregnancy monitoring platform, and LAMF Global Ventures Corp. I, a publicly traded special purpose acquisition company, have announced that LAMFs shareholders have voted to approve the previously announced business combination between the two companies. The combined company will operate as Holdco and is expected to be listed on Nasdaq under the ticker symbol NUVO. The transaction is expected to close as soon as practicable.
Acquired-byPublic Trading
growth-positive
Nuvo, Sheba develop AI-powered gestational diabetes platform
Nuvo Group has completed the first phase of a collaboration agreement with Sheba Medical Center’s “Sheba BEYOND.” The partnership focused on a pilot program for gestational diabetes management, shifting non-stress tests to home-based, remote monitoring using Nuvo’s INVU. The next phase of the partnership will integrate the INVU platform into the hospital’s standard of care protocols and utilize data from the pilot program to develop new AI tools to improve pregnancy care management.
PartnersExpand
growth-positive
Philips partners with Nuvo Group for remote pregnancy monitoring and more digital health briefs
Royal Philips is partnering with Nuvo Group to support remote pregnancy monitoring in rural areas. The collaboration aims to improve access to maternity care in rural communities. Additionally, Pear Therapeutics digital therapeutics will be available in Epics App Orchard Gallery, allowing providers to monitor patients using the companys therapeutics within the EHR. AppliedVR, a virtual reality therapeutics startup, has changed the name of its therapeutic system to RelieVRx and appointed a new chief medical officer. The company plans to launch RelieVRx to treat chronic lower back pain.
PartnersCustomers
growth-positive
Nuvo Group and Unified Women's Healthcare Announce Strategic Collaboration Agreement to Introduce a Remote Pregnancy Monitoring Platform Across Affiliate Care Centers
Nuvo Group has entered into a collaboration agreement with Unified Womens Healthcare to pilot the use of its remote pregnancy monitoring platform, INVU, at Genesis OBGYN. The partnership aims to shift medically necessary tests to home-based, remote monitoring using INVU, allowing expectant mothers to wear the sensor band during virtual visits with their physicians. The collaboration will improve patient convenience, adherence to care protocols, and overall patient and provider experience. After the pilot, Unified and Nuvo intend to integrate the INVU platform into Unifieds network of medical affiliate care centers across the United States.
Partners
growth-positive
Nuvo Group Partners with Charité - Universitätsmedizin Berlin to Establish a Remote Fetal Surveillance Protocol for Europe and Study Predictive Analytics on Preeclampsia Patients
Nuvo Group has announced a partnership with Charité – Universitätsmedizin Berlin to bring remote pregnancy monitoring to Europe and explore the use of predictive analytics to improve health outcomes. The partnership aims to define a remote pregnancy care protocol for Germany and Europe, allowing expectant mothers to conduct remote fetal surveillance under the supervision of a physician. The trial also aims to identify predictive pathways for preeclamptic patients. Nuvo Groups INVU™ platform, an FDA-cleared remote pregnancy monitoring system, allows expectant mothers to monitor maternal-fetal health from anywhere. The partnership with Charité will evaluate the improvement of care with remote monitoring and explore the use of predictive algorithms for hypertensive pregnancy disorders. The partnership is expected to revolutionize the delivery of care and increase access to care for patients.
Partners
growth-positive
Nuvo Group Recruits New CEO to Lead Next Stage of Company Growth
Nuvo Group has appointed Kelly Londy as the new CEO, succeeding founder and former CEO Oren Oz. Oz will transition to the role of chief innovation officer. Londy brings significant healthcare experience and a track record of commercialization success to the company. Nuvo aims to revolutionize pregnancy care with its INVU platform, which combines hardware, software, and AI tools for remote pregnancy monitoring. The company has recently added industry leaders to its board of directors. Nuvo received FDA clearance for maternal and fetal heart rate monitoring in 2020 and a supplemental clearance for remote monitoring of uterine activity in May 2021.
Management Changes
growth-positive
FDA greenlights Nuvo Group's uterine activity module
Nuvo Group has received FDA clearance for a new uterine activity module for its INVU system, a remote pregnancy monitoring system. The clearance allows the device to be used for non-stress testing in pregnant individuals who are in their 32nd week of gestation or later. The addition of the uterine activity module provides an alternative to existing methods of measuring uterine activity that have limitations. Nuvo Groups INVU system offers a reliable solution for remote monitoring of fetal wellbeing, providing expectant mothers and healthcare providers with comprehensive care. The femtech market, including prenatal monitoring devices, is growing and expected to reach $1.15 billion by 2025.
Customers
growth-positive
Nuvo Group Announces Appointment of Joseph DeVivo to Board of Directors
Joseph M. DeVivo has been appointed to the board of directors of Nuvo Group Ltd., a company commercializing INVU by Nuvo, a remote pregnancy monitoring platform. DeVivos appointment is expected to support Nuvos mission of improving health outcomes in pregnancy care through the use of data, analytics, and digital tools. DeVivo brings extensive healthcare leadership experience to Nuvo Group, having served in various roles in medical device and healthcare technology companies. His appointment is seen as valuable in optimizing Nuvos offering, accelerating adoption, and advancing maternal and fetal health. Nuvo Group is committed to advancing pregnancy care with new technology and practices through its INVU platform.
Management Changes
growth-positive
Oren Oz of Nuvo tells us about at-home pregnancy care
The article features an interview with Oren Oz, the Founder and CEO of Nuvo, a remote pregnancy management platform. Oz discusses the challenges and adjustments brought by COVID-19, the inspiration behind starting Nuvo, and the companys innovation in transforming pregnancy care. Nuvos flagship offering, the INVU platform, has received FDA clearance for maternal and fetal heart rate monitoring and is working on remote monitoring of maternal uterine activity. The pandemic has positively impacted Nuvos business finances, as the demand for remote monitoring increased. The company has been able to hire employees and continue building on their offerings. Nuvos customer relationship management has evolved with a focus on virtual meetings and using technology to connect with users and clients. The article does not mention any specific customers or investors.
CustomersExpand
growth-positive
Nuvo Group Partners with University of Utah's Child Adaptation and Neurodevelopment (CAN) Lab on Baby Affect and Behavior (BABY) Study
Nuvo Group has partnered with the University of Utahs Department of Psychology on a study to analyze the relationship between prenatal maternal distress and childrens health outcomes. The study, supported by a National Institute of Mental Health grant, will use Nuvos INVU platform to measure maternal and fetal heart rate variability. The research aims to predict the impact of the mothers emotional state during pregnancy on the childs health outcomes. INVUs remote capabilities allow study participants to measure heart rates from home, making it possible to continue the study during the COVID-19 pandemic. The full results of the study are expected in 2023.
Partners
growth-positive
Nuvo Group Submits 510(k) to Federal Drug Administration for Remote Monitoring of Maternal Uterine Activity
Nuvo Group has filed a 510(k) notice with the FDA to add a new uterine activity module to its INVU platform for remote pregnancy monitoring. The module will enable providers to recognize uterine contractions in women being monitored at home, providing a non-invasive alternative to the current standard of care. The INVU platform has already received FDA clearance for remote monitoring of fetal and maternal heart rates. This expansion of the platform will provide expectant mothers and healthcare providers with more comprehensive data on maternal and fetal health. Nuvo Group is committed to advancing pregnancy care with new technology and tools.
Customers
growth-positive
Nuvo Group Forms Commercial Partnership with Axia Women's Health to Offer the First INVU™ Remote Pregnancy Monitoring Platform
Nuvo Group has entered into a commercial agreement with Axia Womens Health, a womens health network, to adopt the INVU remote pregnancy monitoring platform. Axia Womens Health will be the first healthcare provider in the United States to use the platform, which allows expectant mothers to wear a sensor band and have virtual visits with their physicians. The platform provides fetal and maternal heart rate tracings comparable to in-office checks. The agreement allows Axia Womens Health to shift a portion of scheduled appointments to virtual visits and perform remote fetal wellness checks. The partnership aims to advance maternal and fetal health through technology and tools. Nuvo Group sees this agreement as a milestone in transforming care delivery.
Partners
growth-positive
Nuvo Group Announces Appointment of Dr. Stephen K. Klasko to Board of Directors
Nuvo Group has announced the appointment of Stephen K. Klasko, MD MBA, President of Thomas Jefferson University and Chief Executive Officer of Jefferson Health, to its Board of Directors. Dr. Klasko has been a member of Nuvos Strategic Advisory Board since 2019 and brings valuable experience in telehealth and healthcare innovation. Nuvo Group aims to revolutionize pregnancy care delivery and create value for all stakeholders. The company combines proprietary hardware, cloud-based software, and AI tools to optimize the pregnancy care experience. The INVU platform has received FDA clearance for maternal and fetal heart rate monitoring. The appointment of Dr. Klasko is expected to provide insights, strategic guidance, and market connections to support Nuvos growth in the 21st century.
Management Changes
growth-positive
Nuvo Group Named to the 2020 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups
Nuvo Group has been named to CB Insights Digital Health 150 ranking, which showcases the most promising private digital health companies in the world. The ranking highlights startups that are reimagining the traditional healthcare experience. Nuvo Groups INVU platform, a remote pregnancy monitoring platform, has received clearance from the FDA for home use. The company has also announced a partnership with the Hadassah-Hebrew University Medical Center to create data-driven solutions for personalized pregnancy care. The Digital Health 150 startups have raised over $20 billion in funding and include 12 unicorns. Nuvo Group is committed to advancing pregnancy care with new technology and tools.
Partners
Hillel's Tech Corner: Pregnancy care done right
growth-positive
Nuvo Group to Present at the Jefferies Virtual Healthcare Conference
Nuvo Group will present at the 2020 Jefferies Virtual Healthcare Conference to provide a corporate overview for 2020, with a focus on their launch into the U.S. market. They are a private company commercializing INVU, a remote pregnancy monitoring platform. The conference is invitation-only, and interested viewers can access the live webcast through Jefferies website. Nuvo Group is committed to advancing pregnancy care with new technology and tools, and their INVU platform combines hardware and software solutions powered by AI tools. The company has received FDA clearance for maternal and fetal heart rate monitoring and is working towards clearance for remote monitoring of uterine activity.
PartnersExpand
growth-positive
Nuvo Group Announces Partnership with Hadassah-Hebrew University Medical Center to Develop Innovative Pregnancy Population Management Platform
Nuvo Group has announced a collaborative partnership with the Hadassah-Hebrew University Medical Center to develop data-driven solutions for personalized pregnancy care. Under the agreement, Nuvo will have access to Hadassahs database of medical records to create clinical decision support systems integrated into their INVU platform. The partnership aims to improve patient outcomes, lower healthcare costs, and address the challenges in pregnancy care. Nuvo plans to expand into additional collaborations to develop a proprietary pregnancy population management solution. The partnership is seen as a strategic move for Nuvos future growth. The CEO of Nuvo Group believes that the integration of decision support tools based on unique data will offer value to providers and payers. The partnership has been well-received by the Head of the Division of Obstetrics and Gynecology at Hadassah-Hebrew University Medical Centers.
Partners
growth-positive
Nuvo Group Receives FDA Clearance for its Innovative INVU Remote Pregnancy Monitoring System
Nuvo Group has received FDA clearance to market INVU, a remote monitoring platform for pregnancy care. The platform offers measurements of fetal and maternal heart rate through a wireless sensor band. Healthcare providers can now remotely obtain documentation of medical-grade heart rates. The INVU platform will be available by prescription from healthcare providers. The technology aims to provide safe and effective prenatal monitoring solutions remotely, especially during the COVID-19 pandemic. The companys mission is to advance pregnancy care with new technology and tools. Nuvo Group is committed to giving every life a better beginning.
Customers
Nuvo Group Launches a Distinguished Strategic Advisory Board to Address Key Innovations in Connected Pregnancy for Providers and Expectant Mothers
growth-positive
Israeli Startup Nuvo Develops a Home Fetal and Maternal Monitor for High-Risk Pregnancies
Tel Aviv-based startup Nuvo Inc. has developed a belt-like device called Invu that offers non-invasive fetal and maternal monitoring for pregnant women. The device measures indicators of fetal and maternal wellbeing using sensors and provides information directly to the patients phone and a comprehensive report to her physician. Nuvos business model is to charge insurers per report issued, with an estimated cost of $300 per pregnancy. The company has completed a clinical trial with 150 patients and is awaiting approval from the U.S. Food and Drug Administration (FDA). Nuvo expects to start shipping its product in early 2020 and has received letters of intent from one of Israels largest health maintenance organizations.
CustomersPartners
growth-positive
Office Tour: Nuvo Group Offices - Tel Aviv
Nuvo Group, a healthcare technology company, has opened new offices in Tel Aviv. The office design reflects the data-centered and feminine nature of the companys products and provides spaces for innovation. The 1,500 square meter office occupies an entire floor of the Alon Towers in Tel Avivs business center. The design includes a Research and Development HUB that accommodates the companys employees and labs. Custom multi-purpose furniture pieces were created to provide divisions between teams and integrated writing surfaces and storage. The design concept is inspired by the unique nature of the companys primary product, which is soft and feminine in design but based on complex data and technology.
Expand
growth-positive
United States Food and Drug Administration is Reviewing Nuvo Group LTD's Remote Monitoring Platform
Nuvo Group has submitted the PregSense remote monitoring application to the FDA for De Novo classification. If granted clearance, the remote platform will be marketed as Invu by Nuvo. Invu is an investigational device designed for remote pregnancy monitoring, allowing non-invasive measurement of fetal and maternal heart rates. The submission is based on clinical and scientific validation, showing that Nuvos platform accurately extracts heart rates and offers real-time convenience. This regulatory milestone aligns with Nuvo Groups vision of advancing maternal-fetal connected health. The company aims to enable a connected pregnancy where visits are seamlessly connected across various settings. Nuvo Group is committed to transforming pregnancy care through proprietary software solutions and innovative product design.
Customers
growth-positive
Nuvo Group LTD Presents Data on Remote Monitoring in Pregnancy at the 66th Annual Society for Reproductive Investigation (SRI) Meeting
Nuvo Group presented positive results for its investigational remote monitoring technology at a scientific meeting. The study compared Nuvos Invu platform with the current standard of care, cardiotocographs (CTG), and showed that Invu could extract fetal and maternal heart rates comparable to CTG. The study also indicated that Invu has the potential to offer safe and accurate fetal and maternal monitoring in the comfort of a patients home. The partnership with various medical centers highlights the need for better pregnancy data and access to healthcare professionals. Nuvo Group aims to transform pregnancy care through innovative solutions and big data analytics.
PartnersCustomers
growth-positive
Nuvo Group Enhances Commercialization Expertise With The Addition Of Consumer Products Industry Leader Deb Henretta To Its Board Of Directors
Nuvo Group, an emerging leader in maternal-fetal connected health, has appointed Deb Henretta to its Board of Directors. Henretta brings extensive commercialization experience and expertise in digital business transformation in the consumer product and wellness space. Nuvo Group aims to introduce new offerings to a new generation of physicians and parents to transform pregnancy care. Henrettas knowledge and leadership roles in commercializing products that support women and babies will be invaluable in guiding Nuvo Group. She has previously served in leadership positions at Procter & Gamble and currently serves on the Board of Directors at Corning Inc., Meritage Homes Corporation, and S.C. Johnson.
PartnersManagement Changes
growth-positive
Nuvo Group Names Amit Reches As Vice President, AI And Information
Nuvo Group has appointed Amit Reches as Vice President, AI and Information. Reches will lead the companys technological efforts in artificial intelligence in Nuvo Groups wearable monitoring technology, big data analytics, and cloud-based platform. The addition of Reches to the team will help Nuvo Group establish itself as a global leader in AI and maternal-fetal health. Reches previously served as Vice President of R&D at ElMindA ltd., where he led the commercialization of an AI-based platform. Nuvo Group is committed to transforming pregnancy care through proprietary software solutions and innovative product design that utilize big data analytics.
Management Changes
growth-positive
Nuvo Group Raises $30 Million In Financing Led By Shareholder Value Management AG
Nuvo Group, an emerging leader in maternal-fetal connected health, has raised $30 million in financing to accelerate the development of its innovative platform for pregnancy management. The financing was led by Shareholder Value Management AG, which has invested $13 million in the company. Nuvo Group aims to create technology-enabled solutions that use AI, Big Data, and machine learning in wearable devices for remote monitoring. The companys goal is to transform the experience of pregnancy by providing real-time information to mothers and physicians, enabling better management of the pregnancy while reducing costs to health systems. The financing will support the development of cutting-edge technologies and proprietary data and analytics platforms.
Investment
growth-positive
Maternal-Fetal Health Company Nuvo Group Raises $30M
Nuvo Group, a company that develops wearable technologies for pregnancy health, has raised $30 million in a new financing round led by Shareholder Value Management AG. The funding will be used to accelerate the development of Nuvos innovative platform, which aims to provide continuous, consistent, and connected care for expectant parents and healthcare professionals. Nuvo Groups wearable devices, incorporating Artificial Intelligence and Big Data, will enable expecting mothers to connect with their doctors throughout their pregnancy, allowing for better monitoring and informed decision-making. The companys initial product, Preg-Sense, is currently undergoing clinical investigation for FDA clearance.
Investment
growth-positive
Nuvo launches pivotal trial for PregSense home maternity monitor
Nuvo Group has launched a trial of its PregSense maternal fetal monitoring system to compare it against the current standard of care. The trial will assess the agreement between PregSense data collection and values measured by CTG prenatal monitoring. The company aims to challenge the status quo of pregnancy monitoring technology, which has remained largely unchanged for decades. The goal is to create a wireless wearable system that can record fetal and maternal parameters non-invasively and continuously, providing continuous, real-time access to information. The trial is expected to last up to two years.
Customers
growth-positive
Study Compares New Pregnancy Monitoring Technology With Decades Old Standard Of Care
Nuvo Group has announced the start of a clinical trial to compare its PregSense maternal fetal monitoring system with the current standard of care. The trial will be conducted across four sites and involve up to 200 pregnant women. PregSense measures markers of fetal and maternal wellbeing using surface electrodes on the maternal abdomen. The company aims to provide continuous, real-time access to information for expectant parents and health professionals. PregSense is currently undergoing clinical investigation to support FDA clearance and is not yet available for sale in the United States.
Customers
growth-positive
Nuvo Group Names Debra Bass as Global Chief Marketing Officer and President, Nuvo Group America
Nuvo Group has named Debra Bass as Global Chief Marketing Officer and President, Nuvo Group America. Bass will lead the global development of the Nuvo Group brand and the U.S. market introduction of the companys wearable monitoring technologies for maternal-fetal care. The appointment is seen as a positive growth move for the company. Bass joins Nuvo Group from Johnson & Johnson, where she served as President of Global Marketing Services. Nuvo Group recently closed a $15 million financing round led by German institutional investors. The company aims to improve maternal-fetal care by providing continuous, remote, and hassle-free pregnancy monitoring.
Management Changes
growth-positive
Israelis develop wearable device for non-stop fetal monitoring
Israeli medical experts have developed a wearable mobile monitor called PregSense, which provides data on the status of the fetus and the mothers health. The monitor has sensors woven into an elastic harness and a Bluetooth-enabled device that collects and transmits data to a smartphone. The data is stored on a secure cloud-based database accessible only to expectant mothers and their physicians. The Nuvo Group, led by Oren Oz, developed the device and plans to launch a consumer version called Ritmo Beats by the end of 2015. The device aims to provide reassurance to pregnant women and reduce dependency on doctors for monitoring. It also has the potential to detect symptoms that may lead to complications in pregnancy earlier.
Customers
growth-positive
Wearable device provides continuous fetal monitoring
Israeli medical experts have developed a wearable mobile monitor called PregSense, which provides data on the status of the fetus and the mothers health during pregnancy. The monitor has sensors woven into an elastic harness and a bluetooth-enabled device that collects and transmits data to a smartphone. The data is stored on a secure cloud-based database accessible to expectant mothers and their physicians. The device is developed by the Nuvo Group and is expected to change pregnancy care management and provide better care at a lower cost. The consumer version of the product, called Ritmo Beats, is set to launch by the end of 2015.
Customers
Nuvo Team
Employee Info
| Employees (range) | 11-50 |
| Exact count | 48 |
| Team members | 6 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 21 classification IDs that could be used for matching.
Nuvo Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 101/100 |
| Missing | markets |
| BI Verification | Yanina Wainscheinker |
| Registrar ID | 513849000 |
| Crunchbase | nuvo-group |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wainscheinker@sncentral.org |
| Last update | 2024-11-18T00:00:00.000Z |
| Created | 2014-10-29T00:00:00.000Z |
| Claimed | Yes |
| Status detail | Public on NASDAQ on May, 2024; |